These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients. Muniz-Junqueira MI, Braga Lopes C, Magalhães CA, Schleicher CC, Veiga JP. Life Sci; 2005 Nov 04; 77(25):3141-55. PubMed ID: 16005905 [Abstract] [Full Text] [Related]
4. Oxidative stress and erythrocyte integrity in end-stage renal failure patients hemodialysed using a vitamin E-modified membrane. Westhuyzen J, Saltissi D, Stanbury V. Ann Clin Lab Sci; 2003 Nov 04; 33(1):3-10. PubMed ID: 12661892 [Abstract] [Full Text] [Related]
12. Oxidative stress in elderly chronic renal failure patients: effects of renal replacement therapies on cell membrane fluidity. Goi G, Massaccesi L, Baquero Herrera CJ, Musetti C, Ciurlino D, Cusi D, Bertoli S. J Nephrol; 2009 Nov 04; 22(5):630-6. PubMed ID: 19809996 [Abstract] [Full Text] [Related]
13. Effect of hemodialysis on the content of fatty acids in monolayers of erythrocyte membranes in patients with chronic renal failure. Dolegowska B, Kwiatkowska E, Wesolowska T, Bober J, Chlubek D, Ciechanowski K. Ren Fail; 2007 Nov 04; 29(4):447-52. PubMed ID: 17497467 [Abstract] [Full Text] [Related]
18. C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes. Panichi V, Rizza GM, Taccola D, Paoletti S, Mantuano E, Migliori M, Frangioni S, Filippi C, Carpi A. Biomed Pharmacother; 2006 Jan 04; 60(1):14-7. PubMed ID: 16330177 [Abstract] [Full Text] [Related]
20. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?]. Lovcić V, Kes P, Zeljko R, Kusec V. Acta Med Croatica; 2006 Jun 04; 60(3):201-8. PubMed ID: 16933832 [Abstract] [Full Text] [Related] Page: [Next] [New Search]